News | September 27, 2024
Zydus and CSIR-CDRI Lucknow to develop drug for CKD induced Osteoporosis
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
This partnership aims to accelerate research and development into innovative treatments and, if successful, will generate milestones and royalties
Olverembatinib, a novel drug developed by Ascentage Pharma with support from the National Major New Drug Development program
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
Aurigene.AI is an end-to-end solution for small molecule drug discovery
This Phase III clinical trial is a randomized, double-blind, placebo-controlled, multicenter clinical trial in China to evaluate the safety and efficacy of ASC40
Argo will receive upfront payments of US$ 185 million from Novartis and is eligible to receive potential option and milestone payments as well as tiered royalties on commercial sales.
Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
Innovent also obtains an exclusive option to license in the future development, manufacturing and commercialization rights of SGB-3908
The company has raised US$4.5 million in funding for its AI operating system
Subscribe To Our Newsletter & Stay Updated
